ad

Can AI help with saying goodbye to the deceased? Grief professor Lonneke investigates

Can AI help with saying goodbye to the deceased? Grief professor Lonneke investigates

Professor Lonneke Lenferink is conducting research into the use of artificial intelligence in grief therapy. Her study explores whether interacting with digital recreations of deceased loved ones through AI can help bereaved individuals process severe grief.

Related articles

Camera glasses offer solution for the blind and visually impaired: 'Make them an assistive device'

Camera glasses offer solution for the blind and visually impaired: 'Make them an assistive device'

While smart glasses like the Ray-Ban Meta face criticism for privacy concerns regarding unauthorized filming, they offer significant benefits for blind and visually impaired users. Experts are now advocating for these devices to be officially recognized and marketed as medical aids.

How to talk to your child about smartphone use: Checking is okay, but don't do it secretly

How to talk to your child about smartphone use: Checking is okay, but don't do it secretly

With 60 percent of Dutch children in eighth grade already owning a smartphone, experts advise parents to actively guide and discuss safe online behavior with their children. Rather than secret monitoring, parents are encouraged to establish clear agreements and open communication regarding digital usage.

Brain organoids finally allow for testing of drugs against brain diseases

Brain organoids finally allow for testing of drugs against brain diseases

Researchers in the Netherlands have successfully developed mini-brains that could enable more effective testing of treatments for debilitating brain diseases. These organoids may even possess the potential for basic cognitive activity.

Longevity clinics in Amsterdam are selling expensive treatments promising a longer, healthier life: science or wellness for the wealthy?

Longevity clinics in Amsterdam are selling expensive treatments promising a longer, healthier life: science or wellness for the wealthy?

Moderna shares soar following positive skin cancer vaccine news

Moderna shares soar following positive skin cancer vaccine news

Moderna shares surged nearly 88 percent on Wall Street following the announcement of positive clinical trial results for a new skin cancer vaccine. The study indicates that the vaccine effectively reduces the risk of cancer recurrence or spread.